Proposed Federal Rules Let Patients Compare Healthcare Costs on Their Smartphones

Another push for price transparency steps up pressure on medical laboratories and anatomic pathology groups to develop compliance strategies Clinical laboratories and anatomic pathology groups are under increasing pressure to develop strategies for making their test prices more accessible to patients. Those pressures are likely to grow due to newly proposed federal regulations that aim to allow patients to compare prices for healthcare services on their smartphones. This new proposed rule...

ONC Releases Final Rule for Stage 3 Meaningful Use: What Most Affects Clinical Laboratories and Anatomic Pathology Groups

Meaningful Use Stage 3 focuses on interoperability, which is good news for medical laboratories that must spend time and money to develop effective LIS-EHR interfaces On December 15, 2015, the final rule for Stage 3 meaningful use (MU) went into effect. By now, pathologists and clinical laboratory managers and personnel are well-acquainted with the MU incentive program and the myriad of challenges it presents for almost everyone working in the healthcare sector. Although the implementation of...
;